Knobloch syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1571OMIM:618458Q15.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Knobloch syndrome (also known as Knobloch-Layer syndrome) is a rare autosomal recessive disorder characterized by the combination of high myopia with vitreoretinal degeneration leading to retinal detachment, and occipital skull defects ranging from occipital encephalocele to occipital cutis aplasia. The condition primarily affects the eyes and the central nervous system. The hallmark ocular features include severe myopia present from birth or early infancy, vitreoretinal degeneration, retinal detachment (often bilateral), lens subluxation, and cataracts, which can lead to significant visual impairment or blindness. The occipital defect is variable in severity and may present as a frank encephalocele (protrusion of brain tissue through a skull defect) or as a more subtle finding such as occipital scalp defect (cutis aplasia). Knobloch syndrome is caused by pathogenic variants in the COL18A1 gene, which encodes the alpha-1 chain of type XVIII collagen, a component of basement membranes. This protein plays an important role in the structural integrity of the eye and in the closure of the neural tube during embryonic development. The proteolytic fragment of collagen XVIII, known as endostatin, is involved in angiogenesis regulation and may contribute to the pathophysiology of the disease. Additional clinical features that have been reported in some patients include macular abnormalities, persistent fetal vasculature, epilepsy, and developmental delay, though cognitive function is often normal. There is currently no cure or disease-specific treatment for Knobloch syndrome. Management is supportive and multidisciplinary, involving ophthalmologists for monitoring and surgical treatment of retinal detachments and cataracts, neurosurgeons for management of encephalocele when present, and neurologists if seizures occur. Early detection and intervention for retinal detachment are critical to preserving vision. Genetic counseling is recommended for affected families. Regular ophthalmologic surveillance is essential given the high risk of progressive retinal complications.

Also known as:

Clinical phenotype terms— hover any for plain English:

Macular degenerationHP:0000608Calvarial skull defectHP:0001362Occipital encephaloceleHP:0002085Abnormal vitreous humor morphologyHP:0004327VitreoretinopathyHP:0007773Ectopia lentisHP:0001083
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Knobloch syndrome.

View clinical trials →

No actively recruiting trials found for Knobloch syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Knobloch syndrome community →

No specialists are currently listed for Knobloch syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Knobloch syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Knobloch syndromeForum →

No community posts yet. Be the first to share your experience with Knobloch syndrome.

Start the conversation →

Latest news about Knobloch syndrome

No recent news articles for Knobloch syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Knobloch syndrome

What is Knobloch syndrome?

Knobloch syndrome (also known as Knobloch-Layer syndrome) is a rare autosomal recessive disorder characterized by the combination of high myopia with vitreoretinal degeneration leading to retinal detachment, and occipital skull defects ranging from occipital encephalocele to occipital cutis aplasia. The condition primarily affects the eyes and the central nervous system. The hallmark ocular features include severe myopia present from birth or early infancy, vitreoretinal degeneration, retinal detachment (often bilateral), lens subluxation, and cataracts, which can lead to significant visual im

How is Knobloch syndrome inherited?

Knobloch syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Knobloch syndrome typically begin?

Typical onset of Knobloch syndrome is neonatal. Age of onset can vary across affected individuals.